Advertisement

Breast Cancer Research and Treatment

, Volume 134, Issue 2, pp 867–874 | Cite as

The influence of non-clinical patient factors on medical oncologists’ decisions to recommend breast cancer adjuvant chemotherapy

  • T. May Pini
  • Sarah T. Hawley
  • Yun Li
  • Steven J. Katz
  • Jennifer J. Griggs
Epidemiology

Abstract

The extent to which medical oncologists consider non-clinical patient factors when deciding to recommend adjuvant chemotherapy is unknown. Medical oncologists who treated a population-based sample of early stage breast cancer patients reported to the Los Angeles and Detroit Surveillance, Epidemiology, and End Results registries 2005–2007 were asked how strongly they consider a patient’s ability to follow instructions, level of social support, and level of work support/flexibility in decisions to recommend adjuvant chemotherapy. Responses of 4 (Quite strongly) or 5 (Very strongly) on a five-point Likert scale defined strong consideration. Associations between oncologist/practice characteristics and strong consideration of each non-clinical factor were examined. 134 oncologists (66 %) reported strong consideration of one or more factor. Ability to follow instructions was strongly considered by 120 oncologists (59 %), social support by 78 (38 %), and work support/flexibility by 73 (36 %). Larger percent of practice devoted to breast cancer was associated with lower likelihood of strongly considering ability to follow instructions [odds ratio (OR) 0.98, 95 % confidence interval (CI) 0.97–0.99; P = 0.04]. Increased years in practice was associated with lower likelihood of strongly considering social support (OR 0.96, CI 0.93–0.99; P = 0.011), while non-white race (OR 2.1, CI 1.03–4.26; P = 0.041) and tumor board access (OR 2.04, CI 1.01–4.12; P = 0.048) were associated with higher likelihood. Non-white race was associated with strongly considering work support/flexibility (OR 2.44, CI 1.21–4.92; P = 0.013). Tumor board access (OR 2, CI 1.00–4.02; P = 0.051) was borderline significant. Non-clinical patient factors play a role in medical oncologist decision-making for breast cancer adjuvant chemotherapy recommendations.

Keywords

Decision making Breast cancer Chemotherapy Social environment Socioeconomic factors 

Notes

Acknowledgments

This study was funded by Grants R01 CA109696 and R01 CA088370 from the National Cancer Institute (NCI) to the University of Michigan. Dr. Katz is supported by an Established Investigator Award in Cancer Prevention, Control, Behavioral, and Population Sciences Research from the NCI (K05CA111340). Dr. Li is supported by an Established Investigator Award in Cancer Prevention, Control, Behavioral, and Population Sciences Research from the NCI (K05CA111340-01A1 Supplement, PI: Steven Katz). The collection of Los Angeles County cancer incidence data used in this study was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code §103885. The NCI’s Surveillance, Epidemiology, and End Results (SEER) Program under contract N01-PC-35139 was awarded to the University of Southern California. Contract N01-PC-54404 and agreement 1U58DP00807-01 were awarded to the Public Health Institute. The collection of metropolitan Detroit cancer incidence data was supported by the NCI’s SEER Program under contract N01-PC-35145.

The authors thank our project staff: Barbara Salem, Paul Abrahamse, and Ashley Gay (University of Michigan); Ain Boone, Cathey Boyer, and Deborah Wilson (Wayne State University) and Alma Acosta, Mary Lo, Norma Caldera, Marlene Caldera, Maria Isabel Gaeta, and Meryl Leventhal (University of Southern California). We also thank the American College of Surgeons Commission on Cancer for their support of this project.

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

10549_2012_2116_MOESM1_ESM.pdf (56 kb)
Supplementary material 1 (PDF 56 kb)

References

  1. 1.
    National Comprehensive Cancer Network NCCN Clinical Practice Guidelines in Oncology Version 2 (2011) http://www.nccn.org/professionals/physician_gls/f_guidelines.asp
  2. 2.
    Paik S, Tang G, Shak S et al (2006) Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 24(23):3726–3734PubMedCrossRefGoogle Scholar
  3. 3.
    Levine MN, Whelan T (2006) Adjuvant chemotherapy for breast cancer–30 years later. N Engl J Med 355(18):1920–1922PubMedCrossRefGoogle Scholar
  4. 4.
    Duric VM, Butow PN, Sharpe L, Boyle F, Beith J, Wilcken NRC, Heritier S, Coates AS, John Simes R, Stockler MR (2007) Psychosocial factors and patients’ preferences for adjuvant chemotherapy in early breast cancer. Psychooncology 16(1):48–59PubMedCrossRefGoogle Scholar
  5. 5.
    Leighl N, Gattellari M, Butow P, Brown R, Tattersall MH (2001) Discussing adjuvant cancer therapy. J Clin Oncol 19(6):1768–1778PubMedGoogle Scholar
  6. 6.
    Keating NL, Landrum MB, Klabunde CN, Fletcher RH, Rogers SO, Doucette WR, Tisnado D, Clauser S, Kahn KL (2008) Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity? J Clin Oncol 26(15):2532–2537PubMedCrossRefGoogle Scholar
  7. 7.
    Lutfey KE, Campbell SM, Renfrew MR, Marceau LD, Roland M, McKinlay JB (2008) How are patient characteristics relevant for physicians’ clinical decision making in diabetes?: an analysis of qualitative results from a cross-national factorial experiment. Soc Sci Med 67(9):1391–1399PubMedCrossRefGoogle Scholar
  8. 8.
    Barnhart JM, Wassertheil-Smoller S (2006) The effect of race/ethnicity, sex, and social circumstances on coronary revascularization preferences: a vignette comparison. Cardiol Rev 14(5):215–222PubMedCrossRefGoogle Scholar
  9. 9.
    van Ryn M, Burgess D, Malat J, Griffin J (2006) Physicians’ perceptions of patients’ social and behavioral characteristics and race disparities in treatment recommendations for men with coronary artery disease. Am J Public Health 96(2):351–357PubMedCrossRefGoogle Scholar
  10. 10.
    Bernheim SM, Ross JS, Krumholz HM, Bradley EH (2008) Influence of patients’ socioeconomic status on clinical management decisions: a qualitative study. Ann Fam Med 6(1):53–59PubMedCrossRefGoogle Scholar
  11. 11.
    Bogart LM, Kelly JA, Catz SL, Sosman JM (2000) Impact of medical and nonmedical factors on physician decision making for HIV/AIDS antiretroviral treatment. J Acquir Immune Defic Syndr 23(5):396–404PubMedCrossRefGoogle Scholar
  12. 12.
    Hawley ST, Griggs JJ, Hamilton AS, Graff JJ, Janz NK, Morrow M, Jagsi R, Salem B, Katz SJ (2009) Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients. J Natl Cancer Inst 101(19):1337–1347PubMedCrossRefGoogle Scholar
  13. 13.
    Katz SJ, Hawley ST, Morrow M, Griggs JJ, Jagsi R, Hamilton AS, Graff JJ, Friese CR, Hofer TP (2010) Coordinating cancer care: patient and practice management processes among surgeons who treat breast cancer. Med Care 48(1):45–51PubMedCrossRefGoogle Scholar
  14. 14.
    Dillman DA (2007) Mail and internet surveys: the tailored design method, 2nd edn. Wiley, New YorkGoogle Scholar
  15. 15.
    Hosmer DW, Lemeshow S (2000) Applied logistic regression, 2nd edn. Wiley, New YorkCrossRefGoogle Scholar
  16. 16.
    Rubin DB (1987) Multiple imputation for nonresponse in surveys. Wiley, New YorkCrossRefGoogle Scholar
  17. 17.
    Choudhry NK, Fletcher RH, Soumerai SB (2005) Systematic review: the relationship between clinical experience and quality of health care. Ann Intern Med 142(4):260–273PubMedGoogle Scholar
  18. 18.
    Southern WN, Bellin EY, Arnsten JH (2011) Longer lengths of stay and higher risk of mortality among inpatients of physicians with more years in practice. Am J Med 124(9):868–874PubMedCrossRefGoogle Scholar
  19. 19.
    Bogart LM, Catz SL, Kelly JA, Benotsch EG (2001) Factors influencing physicians’ judgments of adherence and treatment decisions for patients with HIV disease. Med Decis Making 21(1):28–36PubMedCrossRefGoogle Scholar
  20. 20.
    Denberg TD, Kim FJ, Flanigan RC, Fairclough D, Beaty BL, Steiner JF, Hoffman RM (2006) The influence of patient race and social vulnerability on urologist treatment recommendations in localized prostate carcinoma. Med Care 44(12):1137–1141PubMedCrossRefGoogle Scholar
  21. 21.
    Patlak Margie, Balogh Erin, Nass Sharyl, Rapporteurs; Institute of Medicine (2011) Patient-centered cancer treatment planning: improving the quality of oncology care: workshop summary. The National Academies Press, Washington, DCGoogle Scholar
  22. 22.
    Kent DM, Hayward RA (2007) Limitations of applying summary results of clinical trials to individual patients. JAMA, J Am Med Assoc 298(10):1209–1212CrossRefGoogle Scholar
  23. 23.
    Taylor JMG, Cooper KL, Wei JT, Sarma AV, Raghunathan TE, Heeringa SG (2002) Use of multiple imputation to correct for nonresponse bias in a survey of urologic symptoms among African-American men. Am J Epidemiol 156(8):774–782PubMedCrossRefGoogle Scholar
  24. 24.
    Hayward RA, Asch SM, Hogan MM, Hofer TP, Kerr EA (2005) Sins of omission: getting too little medical care may be the greatest threat to patient safety. J Gen Intern Med 20(8):686–691PubMedCrossRefGoogle Scholar
  25. 25.
    Weiner SJ, Schwartz A, Weaver F et al (2010) Contextual errors and failures in individualizing patient care: a multicenter study. Ann Intern Med 153(2):69–75PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2012

Authors and Affiliations

  • T. May Pini
    • 1
  • Sarah T. Hawley
    • 2
  • Yun Li
    • 3
  • Steven J. Katz
    • 4
  • Jennifer J. Griggs
    • 5
  1. 1.Department of Clinical Cancer Prevention, Division of Cancer Prevention and Population SciencesThe University of Texas M.D. Anderson Cancer CenterHoustonUSA
  2. 2.Division of General Medicine, Department of Internal MedicineUniversity of MichiganAnn ArborUSA
  3. 3.Department of BiostatisticsUniversity of MichiganAnn ArborUSA
  4. 4.Division of General Medicine, Department of Internal MedicineUniversity of MichiganAnn ArborUSA
  5. 5.Division of Hematology/Oncology, Department of Internal MedicineUniversity of MichiganAnn ArborUSA

Personalised recommendations